GSK (GSK) Q3 2026 Earnings Call Transcript
Specialty medicines surged 15% as oncology and respiratory treatments drove growth.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- GSK (GSK) Q3 2026 Earnings Call Transcript nasdaq.com